By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kite Pharma, Inc. 

2225 Colorado Avenue

Santa Monica  California  90404  U.S.A.
Phone: 301-824-9999 Fax: n/a


Company News
Kite Pharma (KITE) Announces Appointment Of Renowned Cancer Researcher, Owen N. Witte, M.D., To Its Board Of Directors 3/16/2017 8:51:37 AM
Kite Pharma (KITE) Highlights Publication From NCI Demonstrating Durable Complete Remissions In Patients With Relapsed/Refractory Non-Hodgkin Lymphoma Following Low Dose Conditioning Chemotherapy And Anti-CD19 CAR T-Cell Therapy 3/15/2017 8:09:36 AM
Kite Pharma (KITE) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters’ Option To Purchase Additional Shares 3/8/2017 8:07:33 AM
Kite Pharma (KITE) Release: Richard L. Wang Named Chief Executive Officer Of Fosun Kite Biotechnology Co., Ltd., A Joint Venture To Lead Development Of Axicabtagene Ciloleucel And Other Engineered T-Cell Therapies For Treatment Of Cancers In China 3/6/2017 6:48:33 AM
Kite Pharma (KITE) Announces Commencement Of Public Offering Of Common Stock 3/2/2017 8:16:15 AM
Kite Pharma (KITE) Announces Pricing Of Public Offering Of Common Stock 3/2/2017 7:39:44 AM
Kite Pharma (KITE) Announces Participation In Landmark Alzheimer’s A4 Study Evaluating Its Novel Retinal Imaging Technology 2/28/2017 6:34:11 AM
Kite Pharma (KITE) Reports Fourth Quarter And Full Year 2016 Financial Results 2/28/2017 6:18:24 AM
Kite Pharma (KITE)'s CAR-T Blood Cancer Candidate Succeeds in Major Study 2/28/2017 5:57:53 AM
JPM17: Kite Pharma (KITE)'s Strategy for Commercializing Its Lead CAR-T Drug 1/12/2017 6:44:40 AM